Main > ONCOLOGY (**) > CholangioCarcinoma>MET> > TREAT.: > FR. S. ID-1 Tablets (IDH1 Mutation)

---

works by decreasing abnormal production of the oncometabolite 2-HG

FR. S. ID-1 Tablets (IDH1 Mutation)'s subsections
(*) USA Approval Date: 2021. 08.25.
Company
Generic Name: ivosidenib
HG: HydroxyGlutarate
ID: isocitrate dehydrogenase
Patent>Assignee; Claims; No.; Etc.
Patent>UpDate: 2021. 08.24
RTM
RTM Web-Site

FR. S. ID-1 Tablets (IDH1 Mutation)'s products
This section has no products